Expert Advice 15 Mar 2024 Is biotechnology a good career? Here are the pros and cons Find out about the pros and cons of pursuing a career in biotechnology, from competitive salaries to dealing with regulatory hurdles. March 15, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Mar 2024 7 oncolytic virus companies you should know about Find out more about 7 oncolytic virus companies advancing their drug candidates through clinical trials to help cancer patients. March 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Mar 2024 6 biotech companies tackling antibiotic resistance Discover six antibiotic companies developing novel therapies in an attempt to overcome the global issue of antibiotic resistance. March 7, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 6 Mar 2024 The biggest private biotech investments in February 2024 The companies BioAge Labs, Latigo Biotherapeutics, and Neurona Therapeutics bagged the biggest private biotech investments in February 2024. March 6, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Feb 2024 6 biotech companies making a difference in pediatric care Take a closer look at six pediatric companies taking innovative approaches to tackle illnesses affecting children. February 29, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 16 Feb 2024 How to get a job in biotech? 5 tips on securing your dream job Discover our top biotech job tips, as we list five things you could do to increase your chances of securing your dream job in the industry. February 16, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 14 Feb 2024 The next leap in pet health: longevity drugs for dogs Find out how we could stave off the heartbreak of saying goodbye to our dogs, as three longevity drugs for dogs could soon be approved. February 14, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2024 RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing? Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time. February 12, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Feb 2024 The biggest private biotech investments in January 2024 Jixing Pharmaceuticals, COUR Pharmaceuticals, and OnCusp Therapeutics bagged the biggest private biotech investments in January 2024. February 7, 2024 - 2 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 31 Jan 2024 New epilepsy drugs: what is in the pipeline? Find out about the new epilepsy drugs currently in the pipeline, as resistance to current AEDs underscores the need for new treatments. January 31, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Jan 2024 Eight mental health biotech companies trying to make a difference to people’s lives Take a closer look at eight mental health companies developing therapies that could make a different to people with mental illnesses. January 25, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 24 Jan 2024 A new chapter in cell therapy: engineered B cells reach the clinic for the first time Cell therapy has drastically improved the scope of treatment for a number of diseases in the last few years. Now, engineered B cells are the latest approach in the field of cell therapy, having recently made it into clinical trials. But what exactly are B cells and how can they be engineered to treat diseases? […] January 24, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email